The findings reveal a novel mechanism by which circZNF79(5) promotes HCC progression through YBX1 stabilization and selective autophagy regulation, highlighting the circZNF79(5)-YBX1-BRCC36 axis as a potential therapeutic target for HCC. The gene discussed is BRCC3; the disease is hepatocellular carcinoma.